Susquehanna International Group, LLP Axsome Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	BUY	$69.39 - $97.64 $3.12 Million - $4.39 Million	45,000 Added 32.26%	184,500 $14.7 Million
Q4 2023 Feb 14, 2024	SELL	$57.42 - $83.61 $637,362 - $928,071	-11,100 Reduced 7.37%	139,500 $11.1 Million
Q3 2023 Nov 14, 2023	SELL	$69.25 - $82.21 $5.33 Million - $6.33 Million	-77,000 Reduced 33.83%	150,600 $10.5 Million
Q2 2023 Aug 11, 2023	SELL	$58.41 - $90.35 $665,874 - $1.03 Million	-11,400 Reduced 4.77%	227,600 $16.4 Million
Q1 2023 May 16, 2023	SELL	$58.39 - $75.0 $4.86 Million - $6.25 Million	-83,300 Reduced 25.85%	239,000 $14.7 Million

Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $8.79 Million - $17.5 Million	-220,100 Reduced 40.58%	322,300 $24.9 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $9.62 Million - $18.6 Million	266,700 Added 96.74%	542,400 $24.2 Million

290

37.1M

401K

464K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.45B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.